Comparison of Salivary Opiorphin in Burning Mouth Syndrome and Healthy Subjects and Its Correlation With Psychiatric Disorders
Clinical and Experimental Dental Research · 2024
DOI: 10.1002/cre2.934 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical and Experimental Dental Research, 2024. Verfasst von Zohreh Dalirsani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Oral and Maxillofacial Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Burning Mouth Syndrome, Saliva, Oligopeptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by Mashhad University of Medical Sciences (961428)., Mashhad University of Medical Sciences.
Abstract (Originalsprache)
Objectives
Burning mouth syndrome (BMS) is a chronic disease in which the patient experiences a burning sensation in the oral mucosa without any pathological cause. Opiorphin is a pentapeptide that prevents pain and can have an antidepressant effect. The aim of this study was to evaluate salivary opiorphin concentration in BMS and healthy subjects. In addition, opiorphin concentration in BMS patients before and after psychiatric treatment was compared and the association between burning severity and psychiatric scores with salivary opiorphin concentration was examined. Materials and Methods This cross‐sectional study included 28 BMS patients and 40 healthy individuals referred to the Department of Oral and Maxillofacial Medicine, Faculty of Dentistry, Mashhad, from September 2018 to August 2019. Patients with proven disease based on clinical and psychiatric examinations were included in the study. Unstimulated salivary opiorphin levels were assessed by ELISA. Statistical analysis was performed using SPSS version 24.
Results
Salivary opiorphin levels were significantly higher in BMS patients (2.16 ± 0.30 ng/mL) than in healthy subjects (1.80 ± 0.36 ng/mL) ( p < 0.001). Opiorphin levels in BMS patients increased insignificantly after psychiatric therapy ( p = 0.212). In addition, there was no significant association between opiorphin levels and age, gender, menopause, burning severity, anxiety, and depression status.
Conclusions
The opiorphin concentration in saliva is higher in BMS patients than in healthy subjects. Most BMS patients also suffer from anxiety and depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oral and Maxillofacial Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Oral and Maxillofacial Medicine, School of Dentistry, Khorasan Shomali University of Medical Sciences, Bojnord, Iran.
- Department of Community and Family Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Oral and Maxillofacial Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Zohreh Dalirsani, Maryam Amirchaghmaghi, Mahshid Malakuti Semnani
Förderung
- This work was supported by Mashhad University of Medical Sciences (961428).
- Mashhad University of Medical Sciences
Zitieren
APA
Dalirsani, Z., Amirchaghmaghi, M., Semnani, M. M., Talebi, M., Hashemy, S. I., Shakeri, M. T., & Taghizadeh, A. (2024). Comparison of Salivary Opiorphin in Burning Mouth Syndrome and Healthy Subjects and Its Correlation With Psychiatric Disorders. Clinical and Experimental Dental Research. https://doi.org/10.1002/cre2.934
Vancouver
Dalirsani Z, Amirchaghmaghi M, Semnani MM, Talebi M, Hashemy SI, Shakeri MT, et al. Comparison of Salivary Opiorphin in Burning Mouth Syndrome and Healthy Subjects and Its Correlation With Psychiatric Disorders. Clinical and Experimental Dental Research. 2024. doi:10.1002/cre2.934
BibTeX
@article{Dalirsani2024,
author = {Dalirsani, Zohreh and Amirchaghmaghi, Maryam and Semnani, Mahshid Malakuti and Talebi, Mahdi and Hashemy, Seyed Isaac and Shakeri, Mohammad Taghi and Taghizadeh, Ava},
title = {Comparison of Salivary Opiorphin in Burning Mouth Syndrome and Healthy Subjects and Its Correlation With Psychiatric Disorders},
journal = {Clinical and Experimental Dental Research},
year = {2024},
doi = {10.1002/cre2.934}
}
EUVIMED